🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Florida › Miami

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Miami, FL keessatti

Qorannoo 24 Leukemia Myeloidii Hamaa f Miami fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Miami Cancer Institute, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Miami Cancer Institute, Miami
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Miami Cancer Institute, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Miami Cancer Institute, Miami
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Miami Cancer Institute, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

Namoota walitti qabaa jiraSadarkaa 2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06504459

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

Namoota walitti qabaa jiraSadarkaa 1
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05886049

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Namoota walitti qabaa jiraSadarkaa 3
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07007312

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

Namoota walitti qabaa jira
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT07469592

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

Namoota walitti qabaa jiraSadarkaa 2/3
  • Bioresearch Partners, Miami
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06788756

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

Namoota walitti qabaa jiraSadarkaa 2
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT05442216

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Miami (peds), Miami
  • Niklaus Children's Hospital, Miami
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Namoota walitti qabaa jiraSadarkaa 2/3
  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT04256317

Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy

Namoota walitti qabaa jiraSadarkaa 2
  • University of Miami, Miami
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT06782542

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Miami, Miami
  • Miami Cancer Institute, Miami
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Bit-2026 · NCT04988555

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Namoota walitti qabaa jiraSadarkaa 1
  • University of Miami Health System, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ama-2026 · NCT05143996

Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ama-2026 · NCT05597306

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 1
  • Sylvester Comprehensive Cancer Center, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT06501196

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Miami - Miller School of Medicine, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2025 · NCT03850574

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
  • University of Miami, Miami
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 25-Ado-2025 · NCT05237258

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

Namoota walitti qabaa jiraSadarkaa 1
  • University of Miami, Miami
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Cam-2025 · NCT06634394

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Miami keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.